Real-world Evidence Solutions Market to be Worth $6.37 Billion by 2031--Exclusive Report by Meticulous Research®

Meticulous Market Research Pvt. Ltd. United States of America United Kingdom

device companies segment is expected to account for the largest share of 39.1% of the real-world evidence (RWE) solutions market. Pharmaceutical businesses are using more and more RWE solutions; these solutions are employed at every stage of the drug development process, from drug discovery to post-marketing surveillance, which accounts for the segment's significant market share. Furthermore, RWE is used by regulatory agencies like the FDA to evaluate the post-market safety of medicines that have been approved, as well as for medication approval. To reduce the likelihood of medication failure, pharmaceutical companies are implementing RWE technologies.

Among all the regions studied in this report, North America is expected to account for the largest share, 48.9%, of the real-world evidence (RWE) solutions market in 2024The presence of important players, significant R&D expenditures made by pharmaceutical and biotechnology corporations for medication development, and encouraging government initiatives are all factors contributing to this region's significant market share. The region's stake is also being increased by the growing adoption of EHR in the healthcare sector. The region is seeing an increase in public-private funding for projects utilizing RWE technology. For example, the U.S. Food and Drug Administration stated in 2023 that four more U01 grant awards would be made for the projects, which included using RWE technologies to cure cancer and to improve the effectiveness of clinical trials (refer to U.S. FDA).

Browse Sample Report Now- https://www.meticulousresearch.com/product/real-world-evidence-solutions-market-4954 

Scope of the Report:

Real-world Evidence Solutions Market Assessment—by Component

DatasetsDisparate DatasetsEMR/EHR/Clinical DataClaims & Billing DataPharmacy DataProduct/Disease Registries DataGenomics DataOther Disparate DatasetsIntegrated DatasetsConsulting Services

Note: Other Disparate Datasets include data generated from mobile devices, wearable devices, and social media.

Real-world Evidence Solutions Market Assessment—by Application

Market Access & Reimbursement/Coverage DecisionsDrug Development & ApprovalsOncologyNeurologyImmunologyCardiovascular DiseasesOther Therapeutic AreasPost Market SurveillanceMedical Device Development & ApprovalsOther Applications

Note:  1) Other Therapeutic Areas include infectious diseases, musculoskeletal disorders, dermatological diseases, and respiratory diseases.

2) Other Applications include regulatory and clinical decision-making. 

Real-world Evidence Solutions Market Assessment—by End User

Pharmaceutical, Biotechnology, and Medical Device CompaniesHealthcare PayersHealthcare ProvidersOther End Users

Note: Other end users include academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies.

Real-world Evidence Solutions Market Assessment—by Geography

North AmericaU.S.CanadaEuropeGermanyFranceU.KItalySpainSwitzerlandBelgiumRest of Europe (RoE)Asia-Pacific (APAC)ChinaJapanIndiaSouth KoreaTaiwanSingaporeAustraliaRest of Asia-Pacific (RoAPAC)Latin AmericaBrazilMexicoRest of Latin America (RoLATAM)Middle East & Africa

Unlock Opportunities: Buy Now-

https://www.meticulousresearch.com/Checkout/63109630?utm_source=PRnewswire&utm_medium=Paid&utm_campaign=Product&utm_content=19-08-2024

Related Reports:

Healthcare IT Market by Product (EHR, CDSS, CPOE, Telehealth, Financial Analytics, Claims Management Services, mHealth, RCM, Analytics, CRM, Population Health, LIS, PACS, VNA) Deployment Mode (On-premise, Cloud) Component, and End User—Global Forecast to 2031

RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post Market Surveillance), and End User (Pharma, Payer, Provider)—Global Forecast to 2029

Real-world Data (RWD) Market by Source (EMR, Claims, Pharmacy, Disease Registries), Application [Market Access, Drug Development & Approvals (Oncology, Neurology), Post Market Surveillance], and End User (Pharma, Payers, Providers)—Global Forecast to 2029

Real-world Evidence Analytics Market by Application [Market Access & Reimbursement, Drug Development & Approval (Oncology, Neurology, Cardiovascular), Post Market Surveillance, Medical Device Development], and End User (Pharma, Payer, Provider)—Global Forecast to 2029

U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), and End User (Pharma Companies, Providers)—Forecast to 2029

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: [phone]
Europe: [phone]
APAC: [phone]
Email- [e-mail]
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/238/real-world-evidence-solutions-market-2031

Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/real-world-evidence-solutions-market-to-be-worth-6-37-billion-by-2031exclusive-report-by-meticulous-research-302225161.html